Herbas VPB

Spausdinti
EN | LT
LT - METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
EN - METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. C07K 16/40 (2006.01)
C07K 16/40 (2013.01)
A61P 3/06 (2006.01)
A61K2039/505 (2013.01)
A61K 39/00 (2006.01)
A61P 11/00 (2018.01)
A61P 7/00 (2006.01)
A61P 27/02 (2018.01)
A61P 9/00 (2006.01)
A61P 3/06 (2018.01)
A61P 9/10 (2006.01)
A61P 43/00 (2018.01)
A61P 11/00 (2006.01)
A61P 7/00 (2018.01)
A61P 27/02 (2006.01)
A61P 9/00 (2018.01)
A61P 43/00 (2006.01)
A61P 9/10 (2018.01)
Europos patentas
(11) Patento numeris 3536712
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 19162319.8
Europos patento paraiškos padavimo data 2012-09-12
(97) Europos patento paraiškos paskelbimo data 2019-09-11
(45) Paskelbimo apie Europos patento išdavimą data 2023-05-31
(46) Apibrėžties vertimo paskelbimo data
Prioriteto paraiškos
(30) Numeris Data Šalis
201161535392 P 2011-09-16 US
201161559162 P 2011-11-14 US
201261641321 P 2012-05-02 US
Išradėjai
(72)
SWERGOLD,, Gary , US
Savininkas
(73) Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591-6706, US
Pavadinimas
(54) METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
  METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)